AustraliaAn article reports on concerns raised by Australian medical experts regarding a new saliva-based endometriosis test developed by French startup Ziwig. The test uses microRNA analysis and AI to detect endometriosis, claiming high accuracy, but experts argue there is insufficient 'real-world data' to support its widespread adoption in Australia. Dr. Marilla Druitt from RANZCOG emphasizes the need for more reliable and accessible diagnostics, noting that while the test shows promise in small trials, it faces challenges in practical application. The test is currently being trialed in France and the UK, with results pending, but Ziwig has not sought approval for trials in Australia. The article highlights the difficulty of diagnosing endometriosis, which often takes six to eight years, and includes personal accounts of affected individuals.
Bias read (Center): The article presents information about a medical test without overtly endorsing or criticizing either side of the debate. It cites expert opinions without taking a clear ideological stance and focuses on scientific and medical concerns rather than political positions.
